November 14, 2005 |
U.S. regulators said Thursday that they had issued warnings to companies that are promoting unproven "alternative" hormone therapies for women. The government sent letters to about 50 firms and websites that market supplements and creams as alternatives to hormone replacement therapy, warning them against making baseless claims that the treatments can help with serious diseases such as cancer, heart disease and osteoporosis.
November 14, 2005 |
Producers of tomatoes, tomato sauce and dietary supplements containing lycopene -- the substance that makes tomatoes red -- will not be allowed to advertise claims that they reduce the risk of many forms of cancer, the Food and Drug Administration said Wednesday. But companies will be able to suggest a limited link between tomatoes and a lowered risk of prostate cancer, the agency said.
October 19, 2005 |
A federal court has temporarily blocked marketers of an oral spray from making claims that the products contain growth hormones and can preserve youth, the government said. The Federal Trade Commission said that Pacific Herbal Sciences, Natural Health Product Inc. and New Star Marketing Group, all of California, have been barred from marketing HGH Revolution and Natural Rejuvenator HGH-R -- which don't actually contain human growth hormone, or HGH. The Oct.
June 8, 2005 |
Justice Department lawyers Tuesday asked a federal judge for sweeping sanctions against the biggest tobacco companies, saying the government had proved a 50-year industry conspiracy to mislead the public with "half truths, deceptions and lies that continue to this day." But without explanation, government attorneys drastically reduced their most expensive demand, scaling back a proposed industry-funded smoking-cessation program from $130 billion to $10 billion.
June 3, 2005 |
Tropicana Products Inc. will stop claiming that its Healthy Heart orange juice will reduce the risk of heart disease and stroke, under a settlement reached with the Federal Trade Commission on Thursday. The FTC had alleged that Tropicana, a unit of PepsiCo Inc., misled consumers with claims that drinking two to three glasses a day of its Healthy Heart brand orange juice would produce dramatic effects on blood pressure and cholesterol.
March 15, 2005 |
Discount brokerage pioneer Charles Schwab Corp. sued the TD Waterhouse Group Inc. on Monday, alleging that its rival's advertisements falsely labeled Schwab as a high-priced firm with inferior service. The trade libel complaint filed in state court underscores Schwab's determination to reclaim its reputation as a bargain brokerage.
March 12, 2005 |
AstraZeneca has received its second warning in four months from the U.S. Food and Drug Administration over what the agency says are misleading claims in its ads for cholesterol-lowering medicine Crestor, the company said in New York. The latest letter said claims that Crestor lowers cholesterol better than Pfizer Inc.'s Lipitor were misleading because it cherry picked results from a study comparing the two medicines.
March 8, 2005 |
Blockbuster Inc. is in talks aimed at resolving an investigation by at least 37 states, including California, into whether the company has deceived customers with its recent "End of Late Fees" advertising campaign, people familiar with the matter said Monday. Blockbuster's television ad campaign, run in January, prompted a lawsuit by New Jersey's attorney general and then the probe by the states' attorneys general.
CALIFORNIA | LOCAL
January 19, 2005 |
An Orange County herbal supplement company has agreed to pay $3.58 million in fines to settle a case involving allegations that it misled consumers by promoting one of its products as a cure for cancer, AIDS and other diseases, authorities announced Tuesday.
January 13, 2005 |
Advertisements for the arthritis drug Celebrex were misleading and unsubstantiated, overstating the pain reliever's benefits and understating the risks, the Food and Drug Administration said. The agency asked for an immediate halt to all ads for Celebrex, which Pfizer Inc. did last month in advance of the agency's letter. A study in December found high doses of Celebrex were associated with an increased risk of heart attack.